about
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patientsEfficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFRAnalysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients.CBX7 is a tumor suppressor in mice and humans.Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer.EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer.The Cause of Death of a Child in the 18th Century Solved by Bone Microbiome Typing Using Laser Microdissection and Next Generation Sequencing.Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspective.miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test.KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond.Applications and limitations of oncogene mutation testing in clinical cytopathology.EGFR analysis: current evidence and future directions.Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study.Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective.ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay.Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment.SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer.UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study.New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group.Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.EGFR mutation detection by microfluidic technology: a validation study.UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status.How to prepare cytological samples for molecular testing.USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study.Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs.Metastasis of colon cancer to the thyroid gland: a case diagnosed on fine-needle aspirate by a combined cytological, immunocytochemical, and molecular approach.Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: a histochemical, immunohistochemical, and molecular report.PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates.Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting.Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas: comment on Li et al (2015).Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
P50
Q28067439-B387303C-E11E-4A1B-B7FF-BE2ACB6FAE17Q33618558-2C97BD9E-DC45-4727-9BE4-56EFA205EF67Q34025645-CFF36B08-DE33-41AD-8C93-8AC83BDDA2DEQ34244202-61D3FD98-939C-4CF6-9B7A-438C6C43E741Q35078128-8FC60D34-C798-4BCC-9E08-9977D5EF7BD6Q35547005-5B5AD17F-303F-4F15-96E0-7A537C82B904Q35654769-8A89CC23-35D2-4741-98F3-310C5A69801FQ36244321-C13CB3F5-B66B-4D3E-A049-4F7EEEF3CF1FQ36289392-7F80B549-E4F4-424F-8BF4-831D0D39ED08Q36297213-CCC8861B-F6A6-498A-8557-4B659C7ECF68Q36364110-333B2F7A-F058-483F-BDB1-343D06FBB1A2Q37282490-5E547300-DE06-4DE7-84C6-CC8D633B6E97Q37698122-81D62053-EC12-467E-A245-65E1431BEBEFQ38136134-98FBA356-13CF-4FDA-ACEF-BB506E94C92BQ38171600-CD1D236C-BC18-41C3-B0CF-D41F7AAC7D5BQ38195265-C253249D-4D2C-4F0E-8B23-B3F65C15E18DQ38375158-DB5CE626-F3DF-4CD7-81CC-C11EA3641045Q38591866-6FEB2174-8637-4BEE-BB75-E464D4286DB6Q38651989-BE136F6A-C6FA-4AA9-88FB-0E5470286212Q38717500-824A1135-03C2-42D8-B144-81C22F4A1203Q38750960-4D630965-0304-45C9-AC8F-D7E6AE8F9E24Q38848784-C7775010-6841-4846-BA02-53F9B4E313FAQ38858694-C4E5E8EA-66AF-45E7-B971-5C6A62DBFFEEQ38881708-90F8E2D1-5A3F-4B15-A2C1-A48B9C349056Q38994695-852CC233-3507-4783-BEF9-761C49C0ADE5Q39051874-27294314-29E9-435B-93B0-1651D29AAB50Q39106800-A22022A0-6287-4B6A-83DE-E81D8A7B0EA8Q39136032-F4C25518-6C15-4844-8518-3B68347CAA43Q39252808-3001FB8B-2E82-4AEE-9A53-29AB2C7ABDEDQ39455457-018FB721-7C91-4DE8-9221-659F7A828AA1Q39636533-9468F1B7-65DB-4396-92D9-6A75DE6AE09BQ39985277-E3BB78D1-2A91-47BF-8F6B-F37174FA39F4Q42348350-5B0CBD39-11BF-4D34-9CB5-D5706B751C92Q43485615-601FD86B-CE68-4FF9-A60D-927BFBEAE452Q46038013-B8B3B3A5-FC10-48B7-8918-60376865A330Q46520924-C6138DE5-8566-4EF7-B92E-D9EED0D744ABQ47130165-A016422C-C1C2-45D3-B310-D67285E77033Q48162778-26B1EA7F-33CE-4A21-A3D4-244470E0D269Q48255185-B017DD24-D8B9-450D-95F5-7AFAD0D011FBQ48314714-8763F8BD-5F8F-4B9F-98A8-F81805586986
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Umberto Malapelle
@ast
Umberto Malapelle
@en
Umberto Malapelle
@es
Umberto Malapelle
@nl
Umberto Malapelle
@sl
type
label
Umberto Malapelle
@ast
Umberto Malapelle
@en
Umberto Malapelle
@es
Umberto Malapelle
@nl
Umberto Malapelle
@sl
prefLabel
Umberto Malapelle
@ast
Umberto Malapelle
@en
Umberto Malapelle
@es
Umberto Malapelle
@nl
Umberto Malapelle
@sl
P106
P1153
23991079600
P31
P496
0000-0003-3211-9957